Improving Brain Tumour Care surveys share your experiences and help create change

What we’re funding

We are the leading funder of brain tumour research in the UK, committing over £50 million to date on pioneering projects that will help adults and children with brain tumours.

We fund research through a competitive, fair and transparent process of best practice called peer review to ensure we only select the very best research that will have a real impact on those affected by brain tumours.

Cannabinoid research in the clinic

Preliminary studies from the lab suggest that cannabinoid chemicals THC and CBD can stop GBM cells from growing. And earlier this year, an early-stage trial in the clinic suggested that adding a specific blend of these chemicals – in the form of a drug called Sativex – to chemotherapy could potentially help treat recurrent GBMs more effectively. We’re poised to start the trial in Summer 2022, but we need your help to raise the much-needed funds before it can start.

Our latest research grants

We're pleased to share our most recent research awards. Our Scientific Advisory Board told us that these are the highest quality grants with the best chance of success. We look forward to seeing their progress in the coming months and years.

Future Leader: Dr Veronica Rendo

Read about how our up and coming research leader Dr Veronica Rendo is working to fight GBM resistance to drugs called MDM2 inhibitors.

Research projects

As part of our research strategy, A Cure Can’t Wait, we have established various funding opportunities to achieve our goals of doubling survival and halving the harm caused by a brain tumour. More information about the different types of grants we fund can be found below:

Child brain tumour research

Current and past research projects to enhance our understanding of tumours and how to treat them

Adult brain tumour research

Read about our current and past research projects, furthering our understanding of adult brain tumours and treatments